Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech company developing systemic oncolytic targeted immunotherapies, released a shareholder letter from CEO…
The new FDA voucher program aims to speed approval of drugs aligned with national health priorities. NRX-100, a preservative-free ketamine,…
AI World Society Circle (“AIWS”) is proud to announce the San Francisco Chapter of its flagship After Hours AI World…
Adageis offers providers tools that simplify operations and improve financial performance as healthcare shifts further toward value-based care. “One of the…
Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is well positioned as platinum and palladium prices have gained considerable momentum in…
Brera Holdings (NASDAQ: BREA), an Ireland-based company executing a multi-club ownership strategy in global football, announced that its portfolio club…
ONAR's technology-first approach combines its proprietary AI platform with strategic agency acquisitions to deliver measurable marketing results for middle-market companies…
Channelchek, a Noble Financial Group, Inc. product and service, reports that Steelcase (NYSE: SCS) delivered first-quarter fiscal 2026 results ahead…
Lantern Pharma uses a proprietary AI platform, RADR®, to guide its oncology drug development, enabling rapid drug candidate identification and…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl…